72 independently checked trend briefs about this subject, newest first.
headlinez.news detected 72 source-qualified news clusters connected to Fda between June 23, 2026 and July 31, 2026. They span 3 newsroom categories and average 9.0 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
Cyclospora outbreaks are fueling regional health concerns and economic strain in the restaurant industry as officials navigate complex data and public messaging.
Cyclospora infections are rising across the U.S., with recent data indicating new outbreak clusters that fall outside the traditional link to lettuce products.
The FDA and Publix have issued a recall for frozen berries across eight states following an E. coli outbreak linked to the products.
Rising cyclosporiasis cases push 11,000 infections into the spotlight as the U.S. food safety system faces fresh scrutiny
An ongoing cyclosporiasis outbreak is shifting consumer shopping patterns and forcing menu adjustments across local food markets and restaurants.
A salmonella outbreak linked to eggs has prompted a massive recall of nearly 1.6 million dozen products across multiple states.
A new medical AI framework sparks debate over FDA benchmarks and the path to superintelligence.
Otsuka’s newly approved ADHD drug Simtriyo opens a $615 million market and signals the company’s next big CNS push.
Nearly 20 million eggs recalled as salmonella outbreak sickens 98, prompting a multi‑state safety sweep
A former FDA chief warns the Cyclospora outbreak is still out of control, citing possible widespread contamination in central Mexico.
A new FDA‑approved drug gives ADHD patients of all ages a first‑in‑class treatment option.
FDA greenlights the first oral pill that could replace cholesterol injections, sparking both hope and caution.
A multi-state salmonella outbreak tied to egg products has triggered a recall of 1.6 million eggs across the United States.
Capricor Therapeutics faces market volatility and legal investigations following the release of FDA staff documents regarding its therapy, Deramiocel.
The FDA has initiated a nationwide recall of levothyroxine sodium tablets, citing the medication as a subpotent drug.
FDA staff have raised significant concerns regarding the efficacy data for Capricor Therapeutics' experimental heart disease therapy for Duchenne patients.
Brooklyn Roasting Company has issued a recall for cold brew concentrate sold in New York and New Jersey due to potential botulism contamination.
Amy’s Kitchen has initiated a massive recall of over 184,000 cans of lentil soup due to a potential defect that may lead to product spoilage.
An FDA advisory panel has voted to permit access to certain peptides, overriding internal objections from agency scientists.
Eli Lilly shares rise as new trial data shows the weight-loss drug retatrutide led to an average weight loss of 56 pounds.
A cyclospora parasite outbreak linked to iceberg lettuce and Taco Bell has expanded across nine states, prompting federal investigations and litigation.
Major retailers including Target, Kroger, and Meijer have initiated a nationwide recall of fruit purée pouches due to reports of potential plastic contamination.
A spreading cyclosporiasis outbreak has prompted a major supply chain shift at Taylor Farms as food businesses navigate declining consumer confidence.
U.S. health agencies have expanded investigations into a cyclosporiasis outbreak now spanning nine states.
A recall of generic Zyrtec antihistamine tablets is underway following reports of potential cross-contamination.
Public health agencies are managing two separate cyclospora outbreaks while consumer behavior shifts amid food safety concerns.
Federal health officials are investigating multiple clusters of cyclosporiasis, with iceberg lettuce identified as the primary point of concern.
Arrowhead Pharmaceuticals stock reaches five-year highs following successful Phase 3 trial results, while shares of competitor Ionis decline.
Health officials are investigating a new cyclospora outbreak as industry players respond to rising infection concerns.
A cyclospora outbreak linked to iceberg lettuce supplied by Taylor Farms has triggered recalls and menu changes at Taco Bell across 34 states.
The FDA is set to review seven peptides, drawing significant attention from health sectors and financial markets regarding the future of longevity medicine.
A nationwide recall of Cetirizine tablets is underway due to reports of cross-contamination with the medication ranitidine.
The FDA has authorized an at-home subcutaneous injection for Leqembi, marking a shift in treatment delivery for early-stage Alzheimer's patients.
General Mills has issued a recall for Pillsbury bread roll products due to the risk of glass contamination.
A new FDA-approved therapy is showing success in treating hypothalamic obesity caused by brain tumors and injuries.
The FDA continues its investigation into Taylor Farms regarding a Cyclospora outbreak despite retracting a recent test result.
The FDA has granted approval for Lipfendra, the first oral PCSK9 cholesterol-lowering treatment developed by Merck.
Federal agencies are investigating a multistate cyclosporiasis outbreak potentially linked to lettuce supplied by Taylor Farms to Taco Bell restaurants.
Celcuity shares declined by 12.6% despite the company receiving its first FDA approval for a breast cancer treatment.
Regulatory scrutiny intensifies as the FDA prepares for a critical panel review on the safety and oversight of peptide substances.
Taylor Farms and Sysco have initiated a product pull of iceberg lettuce sourced from central Mexico following its link to a cyclosporiasis outbreak.
Kalshi has introduced new prediction markets that allow users to place wagers on the outcomes of clinical trials and pending FDA drug decisions.
Investigators have identified a potential link between a cyclosporiasis outbreak and shredded iceberg lettuce supplied to Taco Bell locations.
A nationwide dog food recall is underway following reports that products may contain sharp metal fragments.
The FDA has resumed the public release of drug rejection letters, issuing 14 new Complete Response Letters following a three-month operational pause.
The FDA has granted approval for Sanofi’s Sarclisa, marking the first time a cancer medication has been cleared for delivery via an on-body injector.
The FDA has issued a nationwide recall for 2.5 million bottles of prescription eye drops due to concerns regarding a foreign substance and sterility.
A new FDA bench study finds that trace amounts of metals in tampons do not present a health risk to users.
The FDA has granted accelerated approval to Vera Therapeutics for its new kidney disease drug, Trutakna, targeting primary IgA Nephropathy.
Publix issues nationwide recall of frozen blueberries linked to 12 E. coli illnesses across 8 states
Publix has initiated a recall of frozen blueberries linked to 12 cases of E. coli-related illness.
Regulatory changes and new active ingredients are shifting sunscreen from a cosmetic staple to a clinical health requirement.
FDA’s most severe recall ever for potato chips disrupts summer snacking as salmonella risk escalates nationwide
The DEA has moved to classify the kratom compound 7-OH and related substances as Schedule I drugs, marking a significant shift in federal policy.
An upcoming FDA advisory panel review of seven peptide compounds has triggered scrutiny regarding potential conflicts of interest among selected experts.
Leadership transitions at the FDA coincide with a significant regulatory rejection for Unicycive Therapeutics.
The FDA has launched its PreCheck pilot program, selecting seven participants to accelerate domestic drug manufacturing capabilities.
The FDA is convening a panel of longevity and wellness physicians to weigh the safety and regulatory future of peptides.
FDA greenlights Philip Morris to market Zyn pouches as a lower-risk nicotine alternative to cigarettes
FDA greenlights Philip Morris to market ZYN nicotine pouches as a less harmful alternative to cigarettes